Anti-Trump ‘Women’s March’ Celebrates
Anti-Trump ‘Women’s March’ Celebrates Abortion-on-Demand
Despite its lip service to “diversity,” the media-hyped “Women’s March on Washington” has turned out to be just another front for the abortion lobby, promoted by Planned Parenthood and its cronies.
Ostensibly organized to protest the election of Donald Trump, the march on January 21, 2017, will showcase the losing platform of Hillary Clinton, especially her dogged devotion to abortion-on-demand.
While the march’s website claims that “we join in diversity” by “defending the most marginalized among us,” women who are pro-life or defend traditional marriage and family fall outside the stated qualifications of those who wish to march and are not welcome.
The “unity principles” that narrow the scope of the march specifically espouse “reproductive rights” and “LGBTQIA rights,” while omitting the rights to religious freedom or the fundamental right to life.
“We believe in Reproductive Freedom,” the guidelines state. “This means open access to safe, legal, affordable abortion and birth control for all people, regardless of income, location or education.”
“We must have the power to control our bodies and be free from gender norms, expectations and stereotypes,” it reads.
Although organizers hail the event as a “grassroots effort,” in reality, it is a massive top-down, choreographed assembly paid for by major donors such as George Soros and Planned Parenthood, “helmed by four national co-chairs and a national coordinating committee who are working around the clock to pull it all together.”
The list of “Partners” of the event reads like a who’s who of radical feminism, and includes Catholics for Choice, the Center for Reproductive Rights, The Coalition of Nasty Women, EMILY’s List, Free the Nipple, GLAAD, NARAL Pro-Choice America Foundation, National Abortion Federation, National Center for Lesbian Rights, National Institute for Reproductive Health, Pussyhat Project, and, of course, Planned Parenthood.
The usual Hollywood shills for the abortion lobby will also be out in full force.
Planned Parenthood advocate Scarlett Johansson, for instance, announced, “I am marching on Washington to let our next president know that we, men and women alike, will not stand down or be silenced and will fight to protect our bodies and our choices.”
Actress Debra Messing of Will & Grace went further still, saying, “An attack on Planned Parenthood is an attack on all American women.”
Conspicuous by their absence will be the tens of millions of “American women” who believe in the right to life for all, including the unborn.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
High Stakes and Deep Insights Await in Houston Cracking the nut of lower-middle market transactions ain’t a walk in the park. M&A Source®'s Fall 2026 Conference is gearing up to address the very dramas that lurk behind the scenes. Kicking off November 2-4 at the opulent JW Marriott in Houston, Texas, the event is looking to assemble a heavyweight lineup of...
Continue Reading
A Mess That Investors Can't Ignore If you're holding onto Endava plc shares, you've probably felt that gut-punch lately. Yeah, things are getting heated with a class action lawsuit alleging the company played fast and loose with its accounting practices. The complaint's about some shady dealings that may have thrown off investors' perceptions. The Core Allegations This...
Continue Reading
Big Moves in Immuno-Oncology: Astellas' Latest Bet You hear 'immuno-oncology,' you think breakthrough, right? Well, friends, that's what Astellas and Audax Biosciences are shooting for with their fresh handshake over DAX-044. On October 27, 2026, in Tokyo and Melbourne, the two outfits announced they're joining forces to bring this novel immunotherapy to the table. It's...
Continue Reading
A Major Step Forward in AI Infrastructure When two heavyweights clash, you better believe folks are paying attention. OneQode’s deal with AdaniConneX is like a shot across the bow in the AI infrastructure arena. They’re not just dipping a toe in India’s tech waters; they’re diving headfirst with 14 MW of data center muscle right there in Siruseri Sipcot, Chennai....
Continue Reading
A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...
Continue Reading
A New Twist in Illinois: Cash Pop's Arrival Here's something fresh off the press: the Illinois Lottery is now on the ride with Brightstar's Cash Pop. This patented game isn't just another number pick—it's an engaging draw-based game featuring hourly draws with price tags of $1, $2, $5, and $10. It's like clockwork, and trust me, it's more than just the usual spin....
Continue Reading
Etisalat's Stellar Performance: A Deeper Dive When a company like Etisalat drops news of a whopping 46% increase in net profit year-over-year, you sit up and pay attention. Those numbers aren’t just a flash in the pan; they're the result of some serious strategic maneuvers and ripe market conditions. Etisalat isn't resting on its laurels, and their latest financials...
Continue Reading
Amgen's Steady Dividend: A Testament to Stability Diving into the mess that is today's biotech market, Amgen (NASDAQ:AMGN) stands out like a beacon of stability with its recent dividend announcement. The Board's decision to dole out a $2.52 per share dividend for the fourth quarter of 2026 showcases confidence amidst both promising ventures and looming uncertainties....
Continue Reading
A Meeting of Great Minds in Shanghai Alright, listen up. Shanghai's gearing up to be the nerve center for the 2026 World Laureates Forum (WLF), and it's seething with potential. This ain't your regular science fair; it's a lion's den of brainpower set to crack open the future of science and tech. With the heavy-hitters like Nobel and Turing laureates on the docket, you're...
Continue Reading
Dive into Mercado González's Cultural Opening Over in La Habra, Northgate González Market has just flung open the doors to its latest masterpiece: Mercado González. Picture this, a place where the mundanity of grocery shopping melds with a vibrant fiesta of Mexican cuisine, artisanry, and cultural vibes. They transformed an older store into something that commands not...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding Exelon's Upcoming Earnings Report Exelon Corporation (NASDAQ: EXC) is preparing to reveal its quarterly earnings in the near future. Investors are keenly awaiting the results, as they want insights into the company’s performance and projections for the following period. Analysts predict that Exelon will report an earnings per share (EPS) of $0.39,...
Continue Reading
Vallourec Invites Warrant Holders to General Meeting Vallourec has announced a significant upcoming event for its warrant holders, also known as BSA. This meeting is set to take place soon, providing an opportunity for holders to engage with the company's future decisions. Details of the Meeting The general meeting will occur at the Vallourec headquarters, where the...
Continue Reading
Pomerantz LLP Begins Investigation on Behalf of Molina Investors Pomerantz LLP has embarked on an investigation focusing on the interests of investors in Molina Healthcare, Inc. (NYSE: MOH). This inquiry aims to ascertain whether Molina and certain executives may have been involved in any unlawful activities related to securities fraud. Key Financial Findings and Investor...
Continue Reading
Unlocking E-commerce Potential in Grocery Retail In a transformative announcement, SymphonyAI, a leader in predictive and generative AI SaaS products for enterprises, has unveiled groundbreaking insights from its annual grocery e-commerce study. This research indicates a noteworthy 8% growth opportunity for retailers leveraging AI-driven strategies in their connected...
Continue Reading
Honda and Nissan's Strategic Talks Honda (NYSE:HMC) and Nissan (OTC:NSANY) have entered discussions that may lead to a potential merger, a significant move reflecting the shifting landscape of Japan's automotive industry. As these two giants explore deeper ties, it marks a notable strategy to face the competition posed by Tesla and various Chinese car manufacturers....
Continue Reading